Appeal 2007-1998 Application 09/997,829 2. Claim 106 stands rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Myer, Choi and Michal. 3. Claims 108-111 stand rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Myer, Choi, and Wijay. 4. Claims 108-110 and 112 stand rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Myer, Choi and Becker. 5. Claims 118 and 119 stand rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Myer, Choi, and Banas. We reverse. DISCUSSION Claims 103-105, 107, and 113-117 stand rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Myer and Choi. Claim 103 is drawn to an implantable drug eluting device. Claims 104, 105, 107, and 113-117 depend directly or indirectly from claim 103. The device of claim 103 has a compressed undeployed diameter and an expanded deployed diameter. The device comprises three elements: 1. a radially expandable stent comprising a generally cylindrical wall surface and having a hollow bore extending longitudinally therethrough, wherein the generally cylindrical wall surface comprises a plurality of lateral openings in the wall surface; 2. a coating comprising a polymer and a therapeutic substance disposed on the wall surface of the stent; and 3. a tubular outer layer comprising expanded, sintered PTFE tape wound about the outer surface of said stent. 3Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Last modified: September 9, 2013